News & Press: Breaking News

Share Your Opinions with U.S. Pharmacopeia (USP) About Your Experience with CD34+ Cells Enumeration

Thursday, February 27, 2014  
Posted by: ISCT Administrator
Share |

The U.S. Pharmacopeia (USP) is interested in your experiences with cellular testing and/ or therapy especially regarding CD34+ cells.  USP is considering developing new reference materials to be used in cellular enumeration and clinical applications for CD34+ cells.  Your input will help us understand your needs and preferences in terms of resources that could be developed by USP including documentary standards and physical specimens.   

This survey will take approximately 15 minutes to complete.  Please be assured that your responses are confidential and will only be reported in the aggregate.  At the completion of the survey, you may enter a drawing to win one of four $50 gift certificates. 

Please complete the survey by Friday, March 21, 2014.    

 Click on the link below to take the survey:

 If this does not work, copy and paste the URL above into your internet browser.

On behalf of USP’s Biologics and Biotechnology Department, I want to thank you in advance for taking the time to contribute to this important study.  We look forward to your feedback.


Fouad Atouf, Ph.D.
Director, Biologics and Biotechnology – USP-NF
U. S. Pharmacopeia
12601 Twinbrook Parkway
Rockville, MD 20852-1790       

If you have any questions about completing this research survey, please contact Ms. Tracy Needham, Senior Market Research Associate, at 240 221-2078 or by email


© 2018 ISCT. All rights reserved. 
ISCT, and the ISCT logo are registered service marks of the International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of the International Society for Cellular Therapy.